Early-Stage cancer drug study halted after just 3 patients
Disease control
Terminated
This early-phase study aimed to test the safety and dosing of an experimental drug called INCB086550 in Japanese adults with advanced solid tumors that had stopped responding to standard treatments. Only 3 participants were enrolled before the study was terminated early. The main…
Phase: PHASE1 • Sponsor: Incyte Biosciences Japan GK • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC